Exploring the Versatility of Transconjunctival Blepharoplasty: A Retrospective Single-Center Study
Gupta R., Khosa A., Bansal P., Chaudhury G.
Retrospective Study with a reported sample of 88, published in Cureus (2024) — summary generated from the PubMed abstract.
Early human evidence such as case series or small samples is exploring possible benefits.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Retrospective Study
- Journal
- Cureus (2024)
- Reported sample size
- 88
- Source database
- Europe PMC
- PMID
- 39628738
- PMCID
- PMC11614186
- DOI
- 10.7759/cureus.72929
- Citations
- 1
Abstract (original English)
Background Transconjunctival blepharoplasty using the postseptal technique provides direct access to orbital fat, offering reduced risk of complications, such as ectropion, entropion, fat over-resection, and inferior oblique muscle palsy. This study aims to evaluate the clinical outcomes and safety of transconjunctival blepharoplasty using the postseptal technique, focusing on the incidence of postoperative complications, the recovery time, and the feasibility of combining ancillary procedures with this approach. Methods In this retrospective observational study, we analyzed the outcomes of 88 patients who underwent transconjunctival postseptal blepharoplasty at a private hospital in northern India between July 2022 and January 2024. The patients, aged 20 to 76 years, received either general or local anesthesia. Follow-up assessments occurred at one, two, three, six, and 12 weeks postoperatively. Results The study population was composed of 28 men and 60 women, and the median age was 48 years. Of these patients, 31 underwent concurrent excess skin excision, 19 had additional canthoplasty or canthopexy, and 87 received fat transfer to correct a negative vector. Postoperative swelling, bruising, and chemosis were common, typically resolving within one to two weeks. Fourteen patients reported foreign body sensation, which resolved within 48 to 72 hours. The average time for the re
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
- • Without an adequate control group, treatment effects cannot be separated from other factors.
Evidence level
Early human evidence such as case series or small samples is exploring possible benefits.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.